Why animal research?
The future of human and veterinary medicine is bright. Scientific advances are leading to the discovery of newer, better, more targeted medicines that will help treat diseases.
Novartis needs animal research to find innovative, safe and life-saving medicines for patients. Novartis would rather see the end of medical research involving animals. Unfortunately this is not possible today. There are two reasons for that: often, animal studies are needed to better understand complex disease mechanisms; governments and regulatory authorities require that medicines be tested in animals before they are tested in humans.
This is why we must continue with animal research as we look for new medicines for patients.
The health and welfare of human beings is the top priority of all governmental and regulatory organizations around the world. That is why pharmaceutical companies must test their experimental medicines in animals before they are allowed to test them in humans.
The Declaration of Helsinkiestablished in 1964 to set up the code of conduct and principles of research in humans. It states that research in humans must be based on the results of animal research. of the World Medical Association says that it is unethical to give experimental treatments to humans that have not been tested first in laboratory animals. The Declaration is the foundation of many national laws regarding medical research. Healthcare professionals from around the world have signed it.
“Every pharmaceutical company is required to submit animal study results for new medicines before starting any studies in humans.”
Regulatory authorities in countries around the world require all pharmaceutical medicines to be proven safe and effective. In order to do so, these regulations require every pharmaceutical company to submit animal study results for new medicines before starting any tests in humans. The regulations also require companies to carry out additional longer-term toxicity studies in animals to get approval for a new medicine.
This type of regulation is not unique to the pharmaceutical industry. Legislation has been passed and implemented at national and international levels for a range of substances that could be harmful to animals, humans or the environment.